Immunization is a critical component of comprehensive avian disease prevention measures. However, in practical production, failures to achieve expected results after vaccination occur frequently due to various reasons.

I. Poor Vaccine Quality  

Vaccine quality fails to meet standards, such as insufficient viral or bacterial content, poor lyophilization or sealing, oil-water separation in oil emulsion vaccines, or overly coarse aluminum hydroxide adjuvant particles. Vaccines may lose potency or become ineffective during transport or storage due to high temperatures or repeated freeze-thaw cycles. Oil-adjuvant vaccines may freeze, or vaccines may exceed their expiration date.

II. Inappropriate Vaccine Selection  

Inaccurate disease diagnosis leads to mismatches between administered vaccines and the actual disease or serotype.

III. Immunization Program Issues  

When formulating immunization programs, inadequate consideration of various relevant factors results in failure to achieve expected immune effects. For example, neglecting age-related disease susceptibility, epidemic seasons, local disease threats, differences between poultry breeds or lines, maternal antibody interference, impacts of combined or repeated vaccine use, other human factors, and influences of geographical environment and climate conditions.

IV. Vaccine Dilution Errors  

Use of inappropriate diluents, such as failure to use specified special diluents for Marek's disease vaccine; during drinking water immunization, using only tap water without adding skim milk, or using ordinary well water where pH and ions significantly affect the vaccine; sometimes careless errors in calculating or measuring diluent volume lead to excessive dilution; diluting vaccines under direct sunlight or in windy, dusty environments. For vaccines requiring cryopreservation in liquid nitrogen tanks, failure to strictly follow dilution procedures can severely damage vaccine quality. Extended time between dilution and immunization - for instance, some farms needing to vaccinate thousands or even tens of thousands of chickens at once may dilute dozens or hundreds of vaccine bottles simultaneously, leaving them at room temperature for prolonged use, resulting in progressively lower potency, particularly with poor-quality diluents or high environmental temperatures. Adding antibiotics or other chemical drugs to diluents, such as gentamicin or streptomycin - while these don't directly kill vaccine viruses, high concentrations can adversely affect vaccine viruses through changes in pH, ion concentration, and osmotic pressure.

V. Improper Vaccination Route Selection  

Each vaccine has its optimal administration route, and arbitrary changes may affect immune outcomes. For example, Newcastle disease I vaccine administered via drinking water, or infectious laryngotracheitis vaccine given through drinking water or intramuscular injection, yields poor results.

VI. Errors and Omissions During Vaccination  

During drinking water immunization: substandard water quality, quantity, uneven distribution of drinkers, or poor drinker hygiene. During aerosol immunization: inappropriate droplet size, spray height or speed, and non-compliant environmental conditions or airflow. Incorrect eye-drop/nose-drop administration - sometimes chickens are released before vaccine droplets fully enter eyes or nostrils, preventing sufficient vaccine liquid from entering. Improper injection sites or overly thick needles causing backflow when needles are withdrawn; or needles penetrating outside the skin causing vaccine liquid to spray out; or vaccine liquid injected into thoracic/abdominal cavities; or malfunctioning automatic syringe dosage control leading to insufficient injection volumes.

VII. Interference Between Multiple Vaccines  

Strictly speaking, when multiple vaccines are used simultaneously or in close succession, interference between vaccine viruses may occur. For example, infectious bronchitis vaccine virus interferes with Newcastle disease vaccine virus, affecting the latter's immunization effect.

VIII. Effects of Antibacterial Drugs on Live Attenuated Bacterial Vaccines, and Antiviral Drugs on Live Viral Vaccines  

Some operators add antibacterial drugs to feed or drinking water during administration of live attenuated bacterial vaccines (e.g., avian cholera vaccine), significantly affecting vaccine efficacy; using antiviral drugs like ribavirin or moroxydine during viral vaccination may also impact vaccine effectiveness.

IX. Immunodeficiency  

Certain individuals in poultry flocks with γ-globulin or immunoglobulin A deficiencies cannot mount normal immune responses to antigen stimulation, affecting immunization outcomes.

X. Immune Paralysis  

Within certain limits, antibody production increases with antigen dosage, but when antigen quantity exceeds specific thresholds, antibody formation becomes suppressed - a phenomenon called "immune paralysis". Some poultry farms administer excessive repeated injections, potentially causing immune paralysis and failure to achieve expected results.

XI. Immunosuppression  

Immunosuppressed organisms cannot mount expected immune responses after vaccination. Causes include: poor nutritional status (vitamin E/C deficiency, zinc/chlorine/sodium deficiency, hunger, dehydration); various stress factors; poor health status; infections with chicken anemia virus, infectious bursal disease virus, Marek's disease virus, etc.

XII. Immature Immune Organs in Young Poultry  

Some vaccines that show excellent immunization effects in SPF chickens under laboratory conditions may not provide solid immune protection when administered to young poultry flocks, as their immune organs are not fully developed and immune responses remain incomplete. This often explains why young poultry are susceptible to infectious diseases.

XIII. Dysfunction of Non-specific Immune Functions  

Examples include skin or mucosal damage, compromised blood-brain barriers, weakened phagocytosis - all affecting overall immune protection effectiveness.

XIV. Antigenic Variation, Emergence of Very Virulent Strains or New Serotypes  

For instance, with the emergence of very virulent infectious bursal disease virus and Marek's disease virus strains, conventional vaccines often fail to provide effective protection against super virulent strain infections.